Any Level of Smoking Can Lead to Long-term Lung Damage, Study Says
Former smokers and people who smoke relatively few cigarettes per day may experience a faster decline in lung function than people who have never ... Read more
Updates
-
-
Bayer Will Invest $30M in Joint Research Lab for Chronic Lung Diseases
Bayer will invest more than $30 million over the next five years to fund collaborative research projects focused on finding new treatments for chronic ... Read more -
‘Smart Shirts’ Measuring Daily Lung Function May Help Monitor COPD, Other Respiratory Conditions
Shirts with smart technology could be used in place of traditional laboratory equipment to measure lung function, and prove to be particularly useful in ... Read more -
Researcher Awarded Nearly $7.5M to Find Treatments for COPD, Other Disorders
Michael J. Holtzman, MD, has received close to $7.5 million in total funding for research aimed at developing stem cell-based treatments for chronic obstructive ... Read more -
Dorney-Koppel Foundation Spotlights COPD at Stanford Medicine X | CHANGE Conference
The Dorney-Koppel Family Charitable Foundation put chronic obstructive pulmonary disease in the spotlight, leading the educational grand challenge at the recent Stanford Medicine X ... Read more
-
Gala’s RheOx System to Treat Chronic Bronchitis Receives CE Mark for Health and Safety in EU
The RheOx system for the treatment of chronic bronchitis has received the CE mark, ... -
Priority Health Joins Insurers That Will Cover the Zephyr Valve for Emphysema
Priority Health will cover Pulmonx’s Zephyr Endobronchial Valve device as a non-surgical treatment option for severe emphysema, ... -
Vaping Triggers Cellular Responses Similar to Cigarette Smoking, Potentially Increasing Risk of Emphysema
The use of electronic cigarettes, more commonly known as vaping, triggers cellular responses in ... -
Kali-Extracts Launches Website for Cannabis-based COPD Treatment Candidate RespRX
Kali-Extracts has launched a dedicated website for its cannabis-based therapy candidate, RespRX, for chronic obstructive ... -
Breztri Aerosphere Reduced COPD Exacerbations Better Than Approved Therapies, Phase 3 Trial Shows
The triple combination therapy Breztri Aerosphere has successfully achieved its primary goal of reducing ... -
COPD Patients With Acute Exacerbations Should Receive Noninvasive Ventilation Regardless of Certain Characteristics, Study Suggests
Patients with chronic obstructive pulmonary disease (COPD) who are experiencing severe exacerbations should receive ...
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
Tilray Announces Support for Clinical Trial Evaluating Medical Cannabis Efficacy in COPD Patients
News
The effects of vaporized cannabis on symptoms associated with chronic obstructive pulmonary disease (COPD) are the target of a new clinical trial that stems from a partnership between medical cannabis products company Tilray and the Research Institute of the McGill ... Read more